EMILIE WOJCIK: Open Payments
NPI 1851950034 · SYLVAN LAKE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 21 payments from 11 companies in 2025. Trend: 2023 $159 · 2024 $0 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $165 |
| TG Therapeutics, Inc. | 1 | $150 |
| Genentech USA, Inc. | 6 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Octapharma USA, Inc. | 2 | $34 |
| ARGENX US, INC. | 2 | $33 |
| ABBVIE INC. | 1 | $23 |
| UCB, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: BRIUMVI, AMVUTTRA, Ocrevus Zunovo, ONPATTRO, HYQVIA, OCTAGAM IMMUNE GLOBULIN (HUMAN), SKYRIZI, Phesgo.
Industry payments across MI — which companies pay providers there.
